Participation of Caudal Müllerian Mesenchyma in Prostate Development

Journal of Urology

Volumn 180, Issue 5, 2008, Pages 1898-1903

  Cai, Yi ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

estrogens; growth and development; mullerian ducts; prostate; vagina

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

CANCER RISK; CARCINOGENESIS; GENE MUTATION; HETEROZYGOSITY; HUMAN; IN SITU HYBRIDIZATION; MESENCHYME; MUELLERIAN DUCT; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

ANDROGENS; ANIMALS; ESTROGENS; FEMALE; HUMANS; MALE; MESODERM; MULLERIAN DUCTS; ORGANOGENESIS; PROSTATE; RODENTIA; SENSITIVITY AND SPECIFICITY; SEX DIFFERENTIATION;

EID: 53249130642     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.07.025     Document Type: Review

References (50)

1. Ellem S.J., and Risbridger G.P. Treating prostate cancer: a rationale for targeting local oestrogens. Nat Rev Cancer 7 (2007) 621
2. Price D., and Williams-Ashman H.G. The accessory reproductive glands of mammals. In: Young W.C. (Ed). Sex and Internal Secretions. 3rd ed. (1961), Williams, Baltimore 366-448
3. Allard S., Adin P., Gouedard L., di Clemente N., Josso N., Orgebin-Crist M.C., et al. Molecular mechanisms of hormone-mediated Mullerian duct regression: involvement of beta-catenin. Development 127 (2000) 3349
4. Zhan Y., Fujino A., MacLaughlin D.T., Manganaro T.F., Szotek P.P., Arango N.A., et al. Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression. Development 133 (2006) 2359
5. Vainio S., Heikkila M., Kispert A., Chin N., and McMahon A.P. Female development in mammals is regulated by Wnt-4 signalling. Nature 397 (1999) 405
6. Biason-Lauber A., Konrad D., Navratil F., and Schoenle E.J. A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46,XX woman. N Engl J Med 351 (2004) 792
7. Mericskay M., Kitajewski J., and Sassoon D. Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus. Development 131 (2004) 2061
8. Torres M., Gomez-Pardo E., Dressler G.R., and Gruss P. Pax-2 controls multiple steps of urogenital development. Development 121 (1995) 4057
9. Boutin E.L., and Cunha G.R. Does sinus vaginal epithelium persist in the adult mouse vagina?. Dev Dyn 206 (1996) 403
10. Drews U., Sulak O., and Schenck P.A. Androgens and the development of the vagina. Biol Reprod 67 (2002) 1353
11. Mahoney J.J. Genetic and hormonal determination of prostate development in the female rat. J Exp Zool 90 (1942) 413
12. Sugimura Y., Cunha G.R., Norman J.T., and Shannon J.M. Regional differences in the inductive activity of the mesenchyme of the embryonic mouse urogenital sinus. Prostate 7 (1985) 253
13. Cohen R.J., Garrett K., Golding J.L., Thomas R.B., and McNeal J.E. Epithelial differentiation of the lower urinary tract with recognition of the minor prostatic glands. Hum Pathol 33 (2002) 905
14. Imperato-McGinley J., Sanchez R.S., Spencer J.R., Yee B., and Vaughan E.D. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Endocrinology 131 (1992) 1149
15. Cunha G.R. Age-dependent loss of sensitivity of female urogenital sinus to androgenic conditions as a function of the epithelia-stromal interaction in mice. Endocrinology 97 (1975) 665
16. Warot X., Fromental-Ramain C., Fraulob V., Chambon P., and Dolle P. Gene dosage-dependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Development 124 (1997) 4781
17. Podlasek C.A., Duboule D., and Bushman W. Male accessory sex organ morphogenesis is altered by loss of function of Hoxd-13. Dev Dyn 208 (1997) 454
18. Podlasek C.A., Clemens J.Q., and Bushman W. Hoxa-13 gene mutation results in abnormal seminal vesicle and prostate development. J Urol 161 (1999) 1655
19. Drews U., Sulak O., and Oppitz M. Immunohistochemical localisation of androgen receptor during sex-specific morphogenesis in the fetal mouse. Histochem Cell Biol 116 (2001) 427
20. Morgan E.A., Nguyen S.B., Scott V., and Stadler H.S. Loss of Bmp7 and Fgf8 signaling in Hoxa13-mutant mice causes hypospadia. Development 130 (2003) 3095
21. Wolf C.J., Hotchkiss A., Ostby J.S., LeBlanc G.A., and Gray Jr. L.E. Effects of prenatal testosterone propionate on the sexual development of male and female rats: a dose-response study. Toxicol Sci 65 (2002) 71
22. Greene R.R., and Ivy A.C. The experimental production of intersexuality in the female rat with testosterone. Science 86 (1937) 200
23. Naessany S., Habert R., and Picon R. Effects of androgen injections and decapitation on the pituitary-gonadal axis and genital tract of fetal rats at the end of gestation. J Endocrinol 88 (1981) 359
24. Cooke P.S., Buchanan D.L., Lubahn D.B., and Cunha G.R. Mechanism of estrogen action: lessons from the estrogen receptor-alpha knockout mouse. Biol Reprod 59 (1998) 470
25. vom Saal F.S., Timms B.G., Montano M.M., Palanza P., Thayer K.A., Nagel S.C., et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci U S A 94 (1997) 2056
26. Richter C.A., Taylor J.A., Ruhlen R.L., Welshons W.V., and Vom Saal F.S. Estradiol and bisphenol a stimulate androgen receptor and estrogen receptor gene expression in fetal mouse prostate mesenchyme cells. Environ Health Perspect 115 (2007) 902
27. Hayashi N., Sugimura Y., Kawamura J., Donjacour A.A., and Cunha G.R. Morphological and functional heterogeneity in the rat prostatic gland. Biol Reprod 45 (1991) 308
28. Andrews G.S. The histology of the human foetal and prepubertal prostates. J Anat 85 (1951) 44
29. Adams J.Y., Leav I., Lau K.M., Ho S.M., and Pflueger S.M. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate. Prostate 52 (2002) 69
30. Shapiro E., Huang H., Masch R.J., McFadden D.E., Wilson E.L., and Wu X.R. Immunolocalization of estrogen receptor alpha and beta in human fetal prostate. J Urol 174 (2005) 2051
31. Wernert N., Albrech M., Sesterhenn I., Goebbels R., Bonkhoff H., Seitz G., et al. The 'female prostate': location, morphology, immunohistochemical characteristics and significance. Eur Urol 22 (1992) 64
32. McCluggage W.G., Ganesan R., Hirschowitz L., Miller K., and Rollason T.P. Ectopic prostatic tissue in the uterine cervix and vagina: report of a series with a detailed immunohistochemical analysis. Am J Surg Pathol 30 (2006) 209
33. Shapiro E., Huang H.Y., and Wu X.R. Uroplakin and androgen receptor expression in the human fetal genital tract: insights into the development of the vagina. J Urol 164 (2000) 1048
34. Ganesan A., Smith G.H., Broome K., and Steinberg A. Congenital adrenal hyperplasia: preliminary observations of the urethra in 9 cases. J Urol 167 (2002) 275
35. Shibata Y., Ito K., Suzuki K., Nakano K., Fukabori Y., Suzuki R., et al. Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition. Prostate 42 (2000) 45
36. McNeal J.E. Origin and evolution of benign prostatic enlargement. Invest Urol 15 (1978) 340
37. Feneley M.R., Puddefoot J.R., Xia S., Sowter C., Slavin G., Kirby R.S., et al. Zonal biochemical and morphological characteristics in BPH. Br J Urol 75 (1995) 608
38. Wernert N., Gerdes J., Loy V., Seitz G., Scherr O., and Dhom G. Investigations of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on immunohistochemical basis. Virchows Arch A Pathol Anat Histopathol 412 (1988) 387
39. Krieg M., Bartsch W., Thomsen M., and Voigt K.D. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate. J Steroid Biochem 19 (1983) 155
40. el Etreby M.F. Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review. J Steroid Biochem Mol Biol 44 (1993) 565
41. Jin B., Turner L., Walters W.A., and Handelsman D.J. The effects of chronic high dose androgen or estrogen treatment on the human prostate. J Clin Endocrinol Metab 81 (1996) 4290
42. Casella R., Bubendorf L., Schaefer D.J., Bachmann A., Gasser T.C., and Sulser T. Does the prostate really need androgens to grow?. Transurethral resection of the prostate in a male-to-female transsexual 25 years after sex-changing operation. Urol Int 75 (2005) 288
43. Bierhoff E., Walljasper U., Hofmann D., Vogel J., Wernert N., and Pfeifer U. Morphological analogies of fetal prostate stroma and stromal nodules in BPH. Prostate 31 (1997) 234
44. Glenister T.W. The development of the utricle and of the so-called 'middle' or 'median' lobe of the human prostate. J Anat 96 (1962) 443
45. Stephens F.D. Congenital malformations of the rectum, anus and genito-urinary tracts (1963), E, Edinburgh
46. Meikle A.W., Stephenson R.A., Lewis C.M., and Middleton R.G. Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins. J Clin Endocrinol Metab 82 (1997) 571
47. Tang J., Yang J.C., Zhang Y., Liu X., Zhang L., Wang Z., et al. Does benign prostatic hyperplasia originate from the peripheral zone of the prostate?. A preliminary study. BJU Int 100 (2007) 1091
48. Price D. Comparative aspects of development and structure in the prostate. Natl Cancer Inst Monogr 12 (1963) 1
49. Dubbink H.J., Hoedemaeker R.F., van der Kwast T.H., Schroder F.H., and Romijn J.C. Human prostate-specific transglutaminase: a new prostatic marker with a unique distribution pattern. Lab Invest 79 (1999) 141
50. Thielen J.L., Volzing K.G., Collier L.S., Green L.E., Largaespada D.A., and Marker P.C. Markers of prostate region-specific epithelial identity define anatomical locations in the mouse prostate that are molecularly similar to human prostate cancers. Differentiation 75 (2007) 49